Drug and Medication Analysis & Statistics, November 2014 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: Drug, Vaccine, Smoking Cessation, more »

571-610 of about 4 100 reports

Purchase Reports From Reputable Market Research Publishers

Aarti Drugs Ltd. (AARTIDRUGS) - Financial and Strategic SWOT Analysis Review

Aarti Drugs Ltd. (AARTIDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Aarti Drugs's products portfolio includes API, steroids, speciality chemicals, and pharma intermediate. The company offers APIs such as aceclofenac, diclofenac sodium, diclofenac potassium, diclofenac ...

  • Industries : Drug and Medication
Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Adimmune Corporation (Adimmune) is a pharmaceutical company. The company manufactures products, such as vaccines, diagnostics, and biological products. The company's vaccine products include Japan ...

  • Industries : Drug and Medication
  • Countries : Japan, Taiwan
Bliss GVS Pharma Limited (BLISSGVS) - Financial and Strategic SWOT Analysis Review

Bliss GVS Pharma Limited (BLISSGVS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Bliss GVS Pharma Limited (Bliss GVS) is a generic pharmaceutical company. It undertakes the development, manufacturing and marketing of pharmaceutical formulations. The company holds expertise ...

  • Industries : Drug and Medication
  • Countries : India
FDC Limited (FDC) - Financial and Strategic SWOT Analysis Review

FDC Limited (FDC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary FDC Limited (FDC) is a pharmaceutical company. The company manufactures and sells various healthcare products. The products of the company include therapeutic index: anti fungals/dermatological, ...

  • Industries : Drug and Medication
  • Countries : India
IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary IPCA Laboratories Limited (IPCA) is a generic pharmaceutical company. It undertakes the manufacturing and distribution of active pharmaceutical ingredients and formulations. The company's APIs ...

  • Industries : Drug and Medication
  • Countries : Canada, India, Australia
Indoco Remedies Limited (INDOCO) - Financial and Strategic SWOT Analysis Review

Indoco Remedies Limited (INDOCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Indoco Remedies Limited (Indoco Remedies) is a pharmaceutical company. The company manufactures and markets formulations and active pharmaceutical ingredients. It offers products in the fields ...

  • Industries : Drug and Medication
Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company ...

  • Industries : Drug and Medication
  • Countries : India, United States, World, Australia, South Africa, China
Nectar Lifesciences Ltd. (NECLIFE) - Financial and Strategic SWOT Analysis Review

Nectar Lifesciences Ltd. (NECLIFE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Nectar Lifesciences Ltd (NecLife) is an integrated niche pharmaceutical player developing specialized pharmaceutical intermediates, finished dosage formulations and active pharmaceutical ingredients. ...

  • Industries : Drug and Medication
Parabolic Drugs Limited (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

Parabolic Drugs Limited (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Parabolic Drugs Limited (PDL) is a pharmaceutical intermediate company. The company focuses on development and manufacturing of APIs (Active Pharmaceutical Ingredients) and API intermediates. It ...

  • Industries : Drug and Medication
  • Countries : World
Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Surya Pharmaceutical Limited (Surya Pharmaceutical) is a pharmaceutical company. The company discovers, produces and markets active pharmaceutical ingredients (APIs), finished drug formulations ...

  • Industries : Drug and Medication
  • Countries : Singapore, United States
Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Xenetic Biosciences plc (Xenetic) is a bio-pharmaceutical company. It carries out the development of drugs for cancer therapies and vaccines. The company has developed proprietary patented technologies ...

  • Industries : Drug and Medication
  • Countries : United States
Twilight Litaka Pharma Ltd. (TWILITAKA) - Financial and Strategic SWOT Analysis Review

Twilight Litaka Pharma Ltd. (TWILITAKA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Twilight Litaka Pharma Ltd. (TL Pharma) is a pharmaceutical company. The company manufactures drugs and formulations in the form of tablets, capsules, ointment, and liquids. Its products include ...

  • Industries : Drug and Medication
Wintac Limited (524758) - Financial and Strategic SWOT Analysis Review

Wintac Limited (524758) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Wintac Limited (Wintac) is a pharmaceutical and healthcare company. The company develops, manufactures and markets pharmaceutical formulations for healthcare markets. It offers products through ...

  • Industries : Drug and Medication
  • Countries : India
Chunghwa Chemical Synthesis & Biotech Co. Ltd. (1762) - Financial and Strategic SWOT Analysis Review

Chunghwa Chemical Synthesis & Biotech Co. Ltd. (1762) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) is an active pharmaceutical ingredient (API) manufacturer. It undertakes development, manufacturing and commercialization of API's. The company ...

  • Industries : Drug and Medication
AngioGenex, Inc. - Strategic SWOT Analysis Review

AngioGenex, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary AngioGenex, Inc. (AngioGenex) is a bio-pharmaceutical company. The company discovers and develops drugs for the prognosis, diagnosis and treatment of cancer. Its development programs concentrates ...

  • Industries : Drug and Medication
  • Countries : United States
InforMedix Holdings, Inc. (IFMX) - Strategic SWOT Analysis Review

InforMedix Holdings, Inc. (IFMX) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary InforMedix Holdings, Inc. is engaged in the development, patenting and integrating of Med-eXpert system, an integrated Internet-based communication system that offers data analytics; and a database ...

  • Industries : Drug and Medication
  • Countries : United States
Laboratorio Teuto Brasileiro S.A. - Strategic SWOT Analysis Review

Laboratorio Teuto Brasileiro S.A. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Laboratorio Teuto Brasileiro S.A (Teuto) is a pharmaceutical company. The company develops, manufactures and markets pharmaceutical products and services for healthcare market. Its products include ...

  • Industries : Drug and Medication
  • Countries : Brazil
PharmChem, Inc. - Strategic SWOT Analysis Review

PharmChem, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary PharmChem, Inc. (PharmChem) is a healthcare service provider. The organization offers drug testing services to government and corporate customers. Its product PharmChek is a non-invasive tool to ...

  • Industries : Drug and Medication
  • Countries : United States
Scinopharm Taiwan Limited (1789) - Financial and Strategic SWOT Analysis Review

Scinopharm Taiwan Limited (1789) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmaceutical company. The company develops and manufactures APIs and intermediates for pharmaceutical industry. Its products include atazanavir sulfate, ...

  • Industries : Drug and Medication
  • Countries : Taiwan
Retroscreen Virology Limited (RVG) - Financial and Strategic SWOT Analysis Review

Retroscreen Virology Limited (RVG) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Retroscreen Virology Limited (RVL) is a life sciences company. It conducts research and develops antivirals and vaccines for respiratory and enteric viral diseases. The company utilizes its technology ...

  • Industries : Drug and Medication
Adocia (ADOC) - Financial and Strategic SWOT Analysis Review

Adocia (ADOC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Adocia is a biotechnology company. The company offers insulin therapy and the treatment of the diabetic foot ulcer. Its products include PDGF-BB, BioChaperone Insulins combo based on Glargine, ...

  • Industries : Drug and Medication
  • Countries : France
Beximco Pharmaceuticals Ltd. (BXPHARMA) - Financial and Strategic SWOT Analysis Review

Beximco Pharmaceuticals Ltd. (BXPHARMA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Beximco Pharmaceuticals Ltd. (BPL) is a pharmaceutical company. The company manufactures and exports pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its products include ...

  • Industries : Drug and Medication
  • Countries : Bangladesh
Cheezheng Tibetan Medicine Co., Ltd. (002287) - Financial and Strategic SWOT Analysis Review

Cheezheng Tibetan Medicine Co., Ltd. (002287) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Cheezheng Tibetan Medicine Co., Ltd. is a pharmaceutical and healthcare company, based in China. The company processes, manufactures, industrializes and sells traditional Tibetan medicines in China. ...

  • Industries : Drug and Medication
  • Countries : China
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Financial and Strategic SWOT Analysis Review

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Jagsonpal Pharmaceuticals Limited (Jagsonpal) is a pharmaceutical company. The company develops, manufactures and markets bulk drugs and pharmaceutical formulations. Jagsonpal's products include ...

  • Industries : Drug and Medication
  • Countries : Argentina, Switzerland, Sri Lanka, World
Cempra, Inc. (CEMP) - Financial and Strategic SWOT Analysis Review

Cempra, Inc. (CEMP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Cempra, Inc. (Cempra) is a biopharmaceutical company. The company develops antibacterials to the critical medical needs. Its products include solithromycin and TAKSTA. The company's solithromycin ...

  • Industries : Drug and Medication
  • Countries : United States
Formosa Laboratories, Inc. (4746) - Financial and Strategic SWOT Analysis Review

Formosa Laboratories, Inc. (4746) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Formosa Laboratories, Inc. (Formosa) is a pharmaceutical company. The company develops and markets active pharmaceutical ingredients and UV filters. It offers active pharmaceutical ingredients, ...

  • Industries : Drug and Medication
  • Countries : United States
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Financial and Strategic SWOT Analysis Review

Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Zhejiang Hisoar Pharmaceutical Co., Ltd. (Hisoar) is a pharmaceutical company. The company produces and sells special raw drugs and fine chemicals. The company produces raw drugs that include antibody, ...

  • Industries : Drug and Medication
Mylan Pharma UK Limited - Strategic SWOT Analysis Review

Mylan Pharma UK Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mylan is a pharmaceutical company. The company develops and supplies generic medicines. Its products include aceclofenac, aciclovir dispersible, alendronic acid, baclofen, beclometasone, beclometasone, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Mangalam Drugs and Organics Limited (MANGALAM) - Financial and Strategic SWOT Analysis Review

Mangalam Drugs and Organics Limited (MANGALAM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mangalam Drugs and Organics Limited (Mangalam) is a chemical products manufacturing company. The company manufactures chemicals such as API, perfumery chemicals, disperse dye intermediates. It ...

  • Industries : Drug and Medication
  • Countries : India
Renata Limited (RENATA) - Financial and Strategic SWOT Analysis Review

Renata Limited (RENATA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Renata Limited (Renata) is a pharmaceutical company. The company develops and commercializes pharmaceutical and nutritional products for both human and animal use. It manufactures generic pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : Bangladesh
About 11 000 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Statistics in Canada

  • Accessed 21 Nov 2014 00:05 Gmt Gmt
  • November 2014
    11 pages
  • Drug And Medica...  

  • Canada  

View report >

Drug Industry In The Us

November 2014

68 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.